Literature DB >> 17060191

Premature closure of the ductus arteriosus: variable response among monozygotic twins after in utero exposure to indomethacin.

Bahig M Shehata1, Jessica B Bare, Tiffany D Denton, Maria N Habib, Jennifer O Black.   

Abstract

Exposure of the fetus to indomethacin by administration of the drug to the mother may cause many side effects, including premature closure of the ductus arteriosus. Hypoxia is a predisposing factor for premature ductal closure and often occurs after maternal indomethacin therapy. We present two sets of monozygotic twins with twin-to-twin transfusion, where in utero ductal closure occurred in the donor twin while the recipient twin appeared unaffected. This selective closure of the ductus arteriosus suggests that the affected twin was predisposed to hypoxia and thus was more susceptible to ductal closure in response to indomethacin exposure.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17060191     DOI: 10.1080/15513810600908354

Source DB:  PubMed          Journal:  Fetal Pediatr Pathol        ISSN: 1551-3815            Impact factor:   0.958


  4 in total

1.  Minimally invasive fetoscopic interventions: an overview in 2010.

Authors:  Thomas Kohl
Journal:  Surg Endosc       Date:  2010-03-17       Impact factor: 4.584

2.  Spontaneous prenatal ductal closure: postnatal diagnosis?

Authors:  Sissel Irene Nygaard; Olav Bjorn Petersen; Ester Garne; Keld Ejvind Sørensen
Journal:  Pediatr Cardiol       Date:  2008-09-09       Impact factor: 1.655

Review 3.  Clinical pharmacology of indomethacin in preterm infants: implications in patent ductus arteriosus closure.

Authors:  Gian Maria Pacifici
Journal:  Paediatr Drugs       Date:  2013-10       Impact factor: 3.022

4.  Are complicated monochorionic twins more susceptible to indomethacin-induced fetal ductal constriction? Two cases of laser surgery for Twin-Twin Transfusion syndrome.

Authors:  Hakan Erenel; Mehmet Fatih Karslı; Sevim Özge Korkmaz; Cihat Şen
Journal:  Turk J Obstet Gynecol       Date:  2018-09-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.